Drug and pharmaceutical recalls
354 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
Recent recalls
Page 3 of 12- Buprenorphine Hydrochloride injection recalled for crystallization
Par Health USA and Endo USA are recalling certain lots of Buprenorphine Hydrochloride 0.3 mg/mL injection due to crystallization in the vials. Crystallization can affect the drug's effectiveness and safety. The recall affects six specific lots distributed nationwide.
ModerateFDAOct 7, 2026Paragon 28
- Zoladex goserelin implant recalled for temperature abuse
A shipment of Zoladex (goserelin) 3.6 mg implants was left in an unheated FedEx trailer in outdoor conditions for approximately 25.5 hours. This temperature exposure may have affected the medication's stability and effectiveness. The recall affects 296 cartons with lot number YN0099 (expiration 01/31/2028).
ModerateFDAOct 7, 2026TerSera Therapeutics
- Aurolab Trust FOCUS PI eye drops recalled for sterility risk
Aurolab Trust FOCUS PI Hypromellose 0.7% eye drops (a sterile ophthalmic solution) failed to meet sterility standards during manufacturing. Two batches distributed in Virginia are affected. No injuries have been reported.
ModerateFDAOct 7, 2026Aurolab
- Amneal estradiol gel recalled for defective containers
Amneal Pharmaceuticals is recalling specific lots of Estradiol Gel 0.1% because some packets in affected cartons were found to be empty or only partially filled. This means patients may not receive the correct dose of medication. The recall affects 2,592 cartons distributed nationwide.
ModerateFDAOct 7, 2026Amneal Pharmaceuticals
- Glenmark Clindamycin Phosphate Foam recalled for leaking containers
Glenmark Pharmaceuticals received complaints that some cans of Clindamycin Phosphate Foam 1% arrived damaged and were leaking. The affected product was distributed nationwide. No injuries have been reported.
ModerateFDAOct 7, 2026Glenmark
- Ajanta Pharma ranolazine tablets recalled for failed dissolution
Ajanta Pharma USA Inc. is recalling one lot of Ranolazine Extended-Release Tablets, 1000 mg, because the tablets failed to meet dissolution specifications. This means the medication may not release properly in the body, potentially affecting its effectiveness. The recall affects lot DJ25134 with an expiration date of 11/30/2028, distributed nationwide.
ModerateFDAOct 7, 2026Ajanta Pharma
- Amazon acetaminophen caplets recalled for tablet discoloration
Aurobindo Pharma USA Inc has recalled Amazon-brand Extra Strength Acetaminophen 500mg caplets due to consumer reports of discolored tablets in affected bottles. The recall affects 1000-count bottles with lot number ACD124048A and expiration date 11/30/2027 distributed nationwide.
FDAOct 7, 2026Aurobindo Pharma
- Clear Eyes redness relief eye drops recalled for sterility concerns
Prestige Consumer Healthcare is recalling 2 products, both Clear Eyes Redness Relief lubricant and redness reliever eye drops in 0.5 fl oz (15 mL) bottles, one sold with a hang tag. The company cannot assure the drops are sterile. No injuries have been reported, and about 2.4 million bottles were affected.
ModerateFDASep 30, 2026Prestige Consumer Healthcare2 products
- Amneal exenatide injection pens recalled for possible missing medication
Some prefilled pens of Amneal Exenatide Injection may contain no medication due to a defective delivery system. This affects lot AP250095A (expiration 2/28/2027). Patients relying on these pens may not receive their intended dose.
ModerateFDASep 30, 2026Amneal Pharmaceuticals
- Macleods Olanzapine tablets recalled for impurity contamination
Macleods Pharmaceuticals has recalled Olanzapine Tablets USP 5 mg (lot BOB22321A, expiring 07-31-2027) because testing found organic impurities above acceptable limits. The affected bottles were distributed nationwide. No injuries have been reported.
ModerateFDASep 30, 2026MacLeods Pharma
- Walgreens, AvKare and more eye drops recalled for sterility concerns
The FDA has announced a nationwide recall of 9 lubricant eye drops and one eye ointment sold under the Walgreens, AvKare, Reliable-1 Laboratories, TRP Gentle Eyes, Major LubriFresh P.M. and Cameron Pharmaceuticals names. The manufacturer could not confirm that the products are sterile, which is required for eye products. No injuries have been reported.
ModerateFDASep 30, 2026Sterling Pharmaceutical Services9 products
- MENOW SPF35 sunscreen powder recalled for cGMP deviations
MENOW Sunscreen Pressed Powder SPF35 PA+++ was manufactured in ways that do not meet U.S. cosmetic manufacturing standards (cGMP deviations). The affected product was distributed in California only. No injuries have been reported.
ModerateFDASep 30, 2026Shantou Qiwei
- ICU Medical saline injection recalled for potassium chloride mix-up
ICU Medical's 0.9% Sodium Chloride Injection (100 mL) may be mislabeled. Some bags marked as sodium chloride may actually contain potassium chloride instead. This mix-up affects lot 1042188, expiring 10/31/2027, distributed nationwide.
SeriousFDASep 30, 2026ICU Medical
- Vitruvias Therapeutics thyroid tablets recalled for superpotency
Vitruvias Therapeutics is recalling Thyroid Tablets, USP 1/2 Grain (30 mg) because the tablets are superpotent—meaning they contain higher-than-intended levels of active ingredients. This lot was distributed nationwide. The affected lot number is 504950, expiring 09/30/2026.
SeriousFDASep 23, 2026Vitruvias Therapeutics
- Pfizer Dopamine HCl injection recalled for sterility concern
Pfizer has recalled one lot of Dopamine HCl injection (40 mg/mL) distributed nationwide due to a lack of assurance of sterility. The affected lot is NL5230, with an expiration date of October 2027. This is a precautionary measure to ensure patient safety.
ModerateFDASep 23, 2026Pfizer
- Inventia Healthcare chlorthalidone tablets recalled for failed dissolution
Inventia Healthcare Limited's chlorthalidone 25 mg tablets (batch RISA24002, expiring 04/2027) failed to meet dissolution specifications, meaning the tablets may not break down properly in the body. This could affect how well the medication works. About 13,567 bottles were distributed nationwide.
ModerateFDASep 23, 2026Inventia Healthcare
- Taro Lidocaine Ointment recalled for strength variation
Taro Pharmaceuticals is recalling one lot of Lidocaine Ointment USP 5% because testing found the active ingredient strength was outside acceptable limits. The affected lot was identified during long-term stability testing. No injuries have been reported.
ModerateFDASep 23, 2026Sun Pharmaceutical
- Safecor Health Fluphenazine HCl Elixir recalled for stability failure
Safecor Health is recalling specific lots of Fluphenazine HCl Elixir 2.5 mg per 5 mL because they failed stability testing, meaning the medication may not maintain its strength or safety over time. The affected lots were distributed nationwide.
ModerateFDASep 23, 2026Safecor Health6 products
- Sun Pharmaceutical nystatin cream recalled for failed stability specifications
Sun Pharmaceutical is recalling specific lots of Nystatin Cream, USP (15 g tubes) because the medication failed stability testing. This means the cream may not maintain its expected strength or safety over time. The affected lots are AD49605 and AD49606, with expiration dates of 05/31/2027.
ModerateFDASep 23, 2026Sun Pharmaceutical
Par Pharmaceutical dexmedetomidine injection recalled for particulate matterPar Pharmaceutical is recalling two lots of dexmedetomidine HCl injection used in hospitals for patient sedation. The vials contain unwanted particles of cellulose or stopper material that could cause serious blood vessel blockages or clotting if injected into patients. No patient injuries have been reported so far.
SeriousFDASep 18, 2026Par Health
ICU Medical sodium chloride injection recalled for potassium chloride mix-upOne lot of ICU Medical 0.9% Sodium Chloride Injection (a salt solution) was found to contain 10 mEq Potassium Chloride Injection instead. The vial had the correct outer label but the wrong product inside. This was discovered through a customer complaint.
SeriousFDASep 17, 2026ICU Medical
- B. Braun sodium chloride injection recalled for particulate matter
B. Braun Medical Inc. is recalling specific lots of 0.9% Sodium Chloride Injection due to the presence of particulate matter, including iron oxide, inorganic material, cellulose fibers, and polystyrene. The contamination was identified during quality testing. This is a sterile injectable product distributed nationwide.
SeriousFDASep 16, 2026B. Braun
- American Regent epinephrine vials recalled for particulate and sterility concerns
American Regent's epinephrine injection (1 mg/mL, 30 mL vials) may contain particulate matter—including nylon, glass, and other materials—and some vials are broken or leaking. This affects the sterility and safety of the medication. Three specific lot numbers distributed nationwide are involved.
SeriousFDASep 16, 2026American Regent
- OurPharma fentanyl injection recalled for expiration date mismatch
OurPharma LLC's fentanyl citrate 1,000 mcg injection solution has conflicting expiration dates printed on the IV bag and product labeling. The bag shows expiry dates of 07/31/2026 or 11/30/2026, while the product itself is labeled as expiring 12/09/2026. This discrepancy could lead to confusion about when the medication is safe to use.
ModerateFDASep 16, 2026OurPharma
- Baxter Dextrose Injection recalled for stainless steel particles
Baxter Healthcare identified stainless steel particles in certain 2000 mL bags of Dextrose Injection, USP 70%. The contamination affected 606 bags (Lot #Y495066, expiration July 31, 2027) distributed nationwide. No injuries have been reported.
SeriousFDASep 16, 2026Baxter
- Ajanta Pharma fluphenazine tablets recalled for impurity level
Ajanta Pharma USA Inc. is recalling fluphenazine hydrochloride 1mg tablets (NDC 27241-255-01) because stability testing at 18 months found organic impurity levels slightly above specification limits. The tablets contained 1.1% of Impurity-A, exceeding the 1.0% specification. No injuries have been reported.
ModerateFDASep 16, 2026Ajanta Pharma
- ImprimisRx eye drops recalled for subpotent formulation
ImprimisRx NJ LLC is recalling specific lots of Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution used in medical offices because the medication contains lower-than-intended active ingredients. The affected lots may not work as intended for their intended use.
ModerateFDASep 16, 2026ImprimisRx
- Centric Compounding glutathione, Myer's Cocktail vials recalled for elevated endotoxin
Centric Compounding has recalled six lots of Glutathione, Myer's Cocktail, and Tri-Immune Boost injectable vials due to elevated endotoxin contamination. The company has received nine reports of adverse reactions including fever, chills, chest pain, nausea, vomiting, headache, and malaise. Elevated endotoxins in injectable products can cause serious medical events including fever, low blood pressure, inflammatory reactions, anaphylactic shock, and death.
SeriousFDASep 11, 2026Centric Compounding
- Optimal Balance glutathione vials recalled for microbial contamination
Optimal Balance Pharmacy's Glutathione 200 mg/mL injectable solution failed quality testing and was found to contain bacterial endotoxin levels above safe limits. This contamination poses a risk of serious infection or systemic reaction when injected. The affected lot (LG342009076) was distributed nationwide.
SeriousFDASep 9, 2026Optimal Balance Pharmacy
- Baxter sodium chloride IV bags recalled for fiberglass particulate
Baxter Healthcare Corporation is recalling 0.9% Sodium Chloride Injection USP in 500 mL VIAFLEX plastic containers because some bags contain fiberglass particles. The affected lots are Y495523 and Y495523A, expiring October 31, 2027. No injuries have been reported.
SeriousFDASep 9, 2026Baxter